Mumbai redevelopment news: The company wants to explore projects in the old building and society redevelopment segment in the Mumbai Metropolitan Region (MMR). It has no plans to bid for slum rehabilitation projects or other segments such as warehousing and… Read More »Suraj Developers IPO: 16 upcoming projects with 7.46 lakh sqft to come up over 5-6 years
Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs). Read More Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs). Units engaged in oursourced work of… Read More »India#39;s capability and innovation hub market to nearly double to $117 billion by 2027: Report
Gross domestic product fell 0.3% following a gain of 0.2% in September, the Office for National Statistics said Wednesday. The drop was the first since July and exceeded the 0.1% fall economists had forecast. Read More Gross domestic product fell… Read More »UK’s economy shrinks in October, signaling weak end to year
Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro entered the pyroxasulfone market with a substantial 2,000-tonne project approval Read More Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro… Read More »PI Industries fall deepens on fear of rising competition
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. Read More ICICI Securities is bullish on Thyrocare Technologies recommended buy rating… Read More »Buy Thyrocare Technologies; target of Rs 740: ICICI Securities
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. Read More ICICI Securities is bullish on Thyrocare Technologies recommended buy rating… Read More »Buy Thyrocare Technologies; target of Rs 740: ICICI Securities
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. Read More ICICI Securities is bullish on Thyrocare Technologies recommended buy rating… Read More »Buy Thyrocare Technologies; target of Rs 740: ICICI Securities
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. Read More ICICI Securities is bullish on Thyrocare Technologies recommended buy rating… Read More »Buy Thyrocare Technologies; target of Rs 740: ICICI Securities
In a statement, the bank said the lender will shortly integrate its system with the railways ministry to operationalise the pension disbursement process. Read More In a statement, the bank said the lender will shortly integrate its system with the… Read More »RBI authorises Bandhan Bank to disburse pension to retired railway employees
Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Read More Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy… Read More »Sun Pharma#39;s specialty product Ilumetri included in China#39;s national reimbursement drug list
English 
हिन्दी